Takara Bio Inc.
4974.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥100 | ¥116 | ¥209 | ¥270 |
| - Cash | ¥30 | ¥33 | ¥49 | ¥22 |
| + Debt | ¥1 | ¥1 | ¥1 | ¥1 |
| Enterprise Value | ¥71 | ¥84 | ¥161 | ¥249 |
| Revenue | ¥45 | ¥44 | ¥78 | ¥68 |
| % Growth | 3.5% | -44.3% | 15.4% | – |
| Gross Profit | ¥26 | ¥27 | ¥45 | ¥49 |
| % Margin | 57.9% | 61.9% | 57.3% | 72.7% |
| EBITDA | ¥7 | ¥8 | ¥26 | ¥32 |
| % Margin | 14.4% | 18.2% | 33.3% | 46.8% |
| Net Income | ¥1 | ¥1 | ¥16 | ¥20 |
| % Margin | 2.3% | 3.4% | 20.5% | 29.3% |
| EPS Diluted | 8.65 | 12.29 | 132.97 | 164.84 |
| % Growth | -29.6% | -90.8% | -19.3% | – |
| Operating Cash Flow | ¥6 | ¥2 | ¥37 | ¥7 |
| Capital Expenditures | -¥10 | -¥13 | -¥6 | -¥13 |
| Free Cash Flow | -¥4 | -¥11 | ¥31 | -¥6 |